Nicoderm CQ
Nicoderm CQ Nicotine Patches
Quitting smoking is easier with steady, all-day support, and that's exactly what Nicoderm CQ transdermal patches are built to deliver. Made by GlaxoSmithKline, these clear patches release a controlled dose of nicotine polacrilex through the skin over a full 24 hours, helping curb cravings and withdrawal symptoms so you can focus on breaking the habit rather than fighting the urge.
Nicoderm CQ works as a step-down program. Most people who smoke more than 10 cigarettes a day start at the 21 mg patch, using it for the first several weeks before dropping to the 14 mg strength, and finally to a lower dose as the body adjusts to less nicotine. This gradual weaning is what makes patch therapy effective — you taper off nicotine on a schedule instead of quitting cold. Lighter smokers often begin at the 14 mg level. Each box contains 14 patches, roughly a two-week supply at one patch per day.
We carry the Nicoderm CQ 21 mg patch (14 per box) for the initial step and the 14 mg patch for the second phase, so you can order the right strength for wherever you are in your quit plan. Apply one patch each morning to clean, dry, hairless skin, rotating the site daily to reduce irritation, and remove it before bed if vivid dreams or sleep disturbance are a concern.
Patches are a discreet, low-effort option — no chewing, no timing doses through the day, just one application every 24 hours. Pair them with a behavioral quit plan for the best odds of staying smoke-free, and keep both strengths on hand so your step-down transition is never interrupted.